PLI Scheme for Pharmaceutical Manufacturing
- On 24th February, 2021, the Union Cabinet approved Production Linked Incentive (PLI) Scheme for Pharmaceuticals over a period of Financial Year 2020-21 to 2028-29.
- The scheme will be part of the umbrella scheme for the Development of Pharmaceutical Industry.
- It seeks to enhance India's manufacturing capabilities by increasing investment and production in the sector and contributing to product diversification to high value goods in the pharmaceutical sector.
- It also aims to create global champions out of India who have the potential to grow in size and scale using cutting edge technology and thereby penetrate the global value chains.
Need
- At present, low ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 Bharat Cleantech Manufacturing Platform
- 2 Five New Industrial Clusters from India join WEF Initiative
- 3 Logistics Ease Across Different States (LEADS) 2024 Report
- 4 Team Initiative:Boosting Digital Commerce for MSMEs
- 5 Diamond Imprest Authorization Scheme
- 6 National Critical Minerals Mission
- 7 Mutual Credit Guarantee Scheme for MSMEs
- 8 National Manufacturing Mission
- 9 Financialisation of the Economy
- 10 Undercapitalization of Indian Debt Market

- 1 Agriculture Infrastructure and Development Cess
- 2 National Bee Keeping and Honey Mission
- 3 One District One Focus Produce Programme
- 4 Extension of National e-Governance Plan in Agriculture
- 5 RBI Releases Annual Report of Ombudsman Schemes 2019-20
- 6 Tax on EPF Interest: Budget 2021
- 7 New Asset Reconstruction Company
- 8 Mega Investment Textiles Parks (MITRA) Scheme
- 9 Certified Jute Seed Distribution Plan